A clinical trial to study the effect of dexmetomidine as an adjuvant to 0.2% ropivacaine in erector spinae plane block for operative pain relieve in participants undergoing total abdominal hysterectomies
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/07/071636
- Lead Sponsor
- Dayanand Medical College and Hospital, Ludhiana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.American Society of Anaesthesiologists (ASA) I-III
2.Adults (30 to 70 years of age)
3.Female sex
4. Total abdominal hysterectomy patients with infra umblical incision
Exclusion Criteria
1.Refusal for inclusion in study
2.Local anaesthetic allergy / or previous anaphylactic shock from the same
3.Infection at block site
4.Patients with history of opioid abuse
5. Patients who are unable to comprehend VAS score
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time at which patient requests for first rescue analgesic in post-operative period.Timepoint: The time at which patient requests for first rescue analgesic in post-operative period in first 24 hours
- Secondary Outcome Measures
Name Time Method Total opioid consumption in 24 hours <br/ ><br> Bidirectional Visual Analogue Scale (VAS) score will be recorded at rest and on movement at designated intervals. <br/ ><br>3)QoR -15 (Quality of Recovery) questionnaire will be accessed in post-operative period during the time of discharge from PACU . <br/ ><br> <br/ ><br>Timepoint: 24 hours